Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina
- 1 January 2017
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 227, 556-564
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trialEuropean Journal of Preventive Cardiology, 2012
- Comparison of Effectiveness and Safety of Ranolazine Versus Amiodarone for Preventing Atrial Fibrillation After Coronary Artery Bypass GraftingThe American Journal of Cardiology, 2011
- Electrophysiologic basis for the antiarrhythmic actions of ranolazineHeart Rhythm, 2011
- Ranolazine for the Treatment of Heart Failure With Preserved Ejection Fraction: Background, Aims, and Design of the RALI‐DHF StudyClinical Cardiology, 2011
- Ranolazine Increases β-Cell Survival and Improves Glucose Homeostasis in Low-Dose Streptozotocin-Induced Diabetes in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Improvement in Left Ventricular Systolic and Diastolic Performance During Ranolazine Treatment in Patients With Stable AnginaJournal of Cardiovascular Pharmacology and Therapeutics, 2010
- Clinical Features and Outcomes of Women With Unstable Ischemic Heart DiseaseCirculation, 2010
- Effect of Ranolazine on A1C and Glucose Levels in Hyperglycemic Patients With Non-ST Elevation Acute Coronary SyndromeDiabetes Care, 2010
- Clinical Pharmacokinetics of RanolazineClinical Pharmacokinetics, 2006
- Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetesEuropean Heart Journal, 2005